SHAO Tengfei, GE Weihong. Effect of clinical pharmacist intervention on compliance of patients with cerebral infarction[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 178-181. doi: 10.3969/j.issn.1006-0111.2017.02.021
Citation:
|
SHAO Tengfei, GE Weihong. Effect of clinical pharmacist intervention on compliance of patients with cerebral infarction[J]. Journal of Pharmaceutical Practice and Service, 2017, 35(2): 178-181. doi: 10.3969/j.issn.1006-0111.2017.02.021
|
Effect of clinical pharmacist intervention on compliance of patients with cerebral infarction
-
Department of Pharmacy, Nanjing Drum Tower Hospital Affiliated to Medical College of Nanjing University, Nanjing 210008, China
- Received Date: 2016-10-27
- Rev Recd Date:
2017-10-11
-
Abstract
Objective To explore the factors resulting in poor medication compliance in patients with cerebral infarction and study the effect of medication education by pharmacist on the compliance of patients. Methods 128 patients with cerebral infarction recurrence from January to June of 2016 were selected. Patient's medication history and knowledge were evaluated. The compliance was compared before medication education, 3 days and 30 days after medication education. Results Only 36.7% of the patients took drugs every day before hospitalization. The patient's medication knowledge was limited. The poor compliance was related to the absence of medication education. The compliance was improved significantly after medication education. Conclusion Pharmacists play an important role in patient's care. Pharmacists should take responsibility in medication education to improve medication compliance and reduce the recurrence of cerebral infarction.
-
References
[1]
|
Grunberg SM, Deuson RR, Mavros P, et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics[J]. Cancer, 2004, 100(10):2261-2268. |
[2]
|
余华琴,陈华英,任若梅,等. 阿瑞匹坦三联止吐方案用于接受高致吐方案化疗患者的疗效观察[J]. 现代中西医结合杂志,2016,25(3):274-276. |
[3]
|
田奕,王平,马丽君.应用R-INVR国际量表评估阿瑞匹坦、欧赛、地塞米松对于乳腺癌患者化疗所致中重度呕吐治疗效果观察[J]. 中国现代医学杂志,2016,26(18):136-139. |
[4]
|
Hesketh PJ. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting[J]. Cancer Invest, 2000, 18(2):163-173. |
[5]
|
于莉,张晓晔.阿瑞匹坦在实体肿瘤化疗止吐治疗的研究进展[J]. 中国肿瘤临床与康复,2016,23(9):1148-1152. |
[6]
|
Aapro M, Carides A, Rapoport BL, et al. Aprepitant and fosaprepitant:a 10-year review of efficacy and safety[J]. Oncnlogist, 2015, 20(4):450-458. |
[7]
|
郑琪,廖子君,李旭,等. 阿瑞匹坦治疗化疗诱导的爆发性恶心呕吐的临床观察[J]. 山西医科大学学报,2016,47(6):539-543. |
[8]
|
Chu CC, Hsing CH, Shieh JP, et al. The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting[J]. Eur J Pharmacol, 2014, 722:48-54. |
[9]
|
丁荣楣,王平,田奕,等. 阿瑞匹坦辅助预防乳腺癌FAC方案化疗致恶心呕吐的临床观察[J]. 疑难病杂志,2015,14(1):45-48. |
-
-
Proportional views
-